News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MEDA: Edluar Approved in Europe


6/15/2012 10:12:07 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Edluar has received registration approval in Europe via the decentralized procedure with Sweden acting as Reference Member State. Edluar is used for treating sleep disorders and contains zolpidem, a well-documented active ingredient. National registration processes will now follow in each country. The first launches are expected early next year.

Read at BioSpace.com

comments powered by Disqus
MEDA
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES